ACADIA Pharmaceuticals
ACAD
#3376
Rank
C$4.78 B
Marketcap
$28.76
Share price
3.15%
Change (1 day)
-14.24%
Change (1 year)

Earnings for ACADIA Pharmaceuticals (ACAD)

Earnings in 2024 (TTM): C$0.18 Billion

According to ACADIA Pharmaceuticals's latest financial reports the company's current earnings are C$0.92 Billion. In 2023 the company made an earning of -C$72.36 Million, an increase over its 2022 earnings that were of -C$0.31 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for ACADIA Pharmaceuticals from 2003 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) C$0.18 B-354.91%
2023 -C$72.36 Million-76.09%
2022 -C$0.31 Billion27.41%
2021 -C$0.24 Billion-40.38%
2020 -C$0.4 Billion19.88%
2019 -C$0.34 Billion-3.92%
2018 -C$0.35 Billion-15.04%
2017 -C$0.41 Billion6.33%
2016 -C$0.39 Billion64.55%
2015 -C$0.24 Billion77.47%
2014 -C$0.14 Billion143.69%
2013 -C$53.8 Million81.93%
2012 -C$29.58 Million-8.73%
2011 -C$32.4 Million-251.39%
2010 C$21.4 M-133.2%
2009 -C$64.47 Million-30.82%
2008 -C$93.18 Million6.43%
2007 -C$87.55 Million25.89%
2006 -C$69.55 Million36.99%
2005 -C$50.77 Million37.22%
2004 -C$37 Million19.96%
2003 -C$30.84 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$53.13 Million-127.42%๐Ÿ‡บ๐Ÿ‡ธ USA
C$9.84 B 4,979.27%๐Ÿ‡บ๐Ÿ‡ธ USA
C$14.39 B 7,325.76%๐Ÿ‡บ๐Ÿ‡ธ USA
C$24.72 B 12,659.98%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$11.88 Billion-6,229.79%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$54.77 Million-128.26%๐Ÿ‡บ๐Ÿ‡ธ USA